SANXING(SH:601567) Sou Hu Cai Jing·2025-07-31 12:10Group 1 - The core viewpoint of the articles highlights Samsung Medical's stock performance, with a closing price of 22.49 yuan, an increase of 4.31%, and a rolling PE ratio of 13.25, marking a new low in 13 days, with a total market capitalization of 31.604 billion yuan [1] - The average PE ratio for the electric grid equipment industry is 36.15, with a median of 39.64, placing Samsung Medical at the 35th position in the industry ranking [1] - As of March 31, 2025, the number of shareholders for Samsung Medical is 16,366, a decrease of 898 from the previous count, with an average holding value of 352,800 yuan and an average holding quantity of 27,600 shares [1] Group 2 - In the latest quarterly report for Q1 2025, the company achieved an operating income of 3.631 billion yuan, a year-on-year increase of 20.03%, and a net profit of 489 million yuan, reflecting a year-on-year growth of 34.33%, with a sales gross margin of 28.90% [2] - Samsung Medical's PE (TTM) is 13.25, with a static PE of 13.99 and a price-to-book ratio of 2.51, while the total market capitalization is 31.604 billion yuan [2] - The industry averages for PE (TTM) and static PE are 36.15 and 40.35 respectively, with a price-to-book ratio of 3.67, indicating that Samsung Medical's valuation metrics are significantly lower than the industry averages [2]